Multiple Exposures of Plasma to Nanoparticles: A Novel Tool to Personalize Biomolecular Coronas and Fractionate Fluids
- PMID: 40587098
- PMCID: PMC12268827
- DOI: 10.1021/acs.analchem.4c05573
Multiple Exposures of Plasma to Nanoparticles: A Novel Tool to Personalize Biomolecular Coronas and Fractionate Fluids
Abstract
Nanoparticles (NPs) have emerged as a valuable tool for biomarker discovery due to their ability to interact with biological fluids and form biomolecular coronas. In this study, we introduce a multiple exposure method that uses NPs to fractionate biological fluids and obtain personalized coronas. By repeatedly exposing plasma to silica NPs, we observed a progressive change of the biomolecule profile in both the pellet and supernatant. The varying protein and glycan composition of the corona was characterized using techniques such as SDS-PAGE, mass spectrometry, and UHPLC. Notably, the corona's composition evolved with each exposure cycle, reflecting the selective binding of proteins and glycosylated molecules from a corona of high-affinity biomolecules to a more diverse corona with very distinct structures. By tracing the sequential modification of protein and glycan composition, we believe that the method can be useful to trace specific biomarker profiles, offering a noninvasive alternative to conventional diagnostic processes with the potential to become a useful tool for disease monitoring and advanced biomedical applications.
Figures





Similar articles
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.Cochrane Database Syst Rev. 2016 Apr 19;4:CD011621. doi: 10.1002/14651858.CD011621.pub2. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2019 Jul 01;7:CD011621. doi: 10.1002/14651858.CD011621.pub3. PMID: 27093058 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Interventions to reduce harm from continued tobacco use.Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3. Cochrane Database Syst Rev. 2016. PMID: 27734465 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Omenn G. S., States D. J., Adamski M., Blackwell T. W., Menon R., Hermjakob H., Apweiler R., Haab B. B., Simpson R. J., Eddes J. S.. et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics. 2005;5(13):3226–3245. doi: 10.1002/pmic.200500358. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources